Amenta F, Bongrani S, Cadel S, Ferrante F, Valsecchi B, Zeng Y C
Sezione di Anatomia Umana, Università di Camerino, Italy.
Mech Ageing Dev. 1994 Aug;75(2):157-67. doi: 10.1016/0047-6374(94)90084-1.
Treatment with L-deprenyl increases mean and maximum life span in the rat and reverses memory and learning deficits associated with old age. Since only sparse information is available concerning the influence of L-deprenyl administration on the aging brain microanatomy, we have investigated the effect of long-term treatment with L-deprenyl on the structure of the cerebellar cortex in the aged rat. The cerebellar cortex was used since it represents a useful model for assessing age-related changes in nervous system anatomy and function. Male Sprague-Dawley rats were treated from the 19th to the 24th month of age with a daily oral dose of 1.25 mg/kg or 5 mg/kg L-deprenyl. Age-matched rats were left untreated and used as a control group. Eleven-month-old untreated rats were used as an adult reference group. The density of Purkinje and granule neuron profiles as well as the intensity of Nissl's staining within the cytoplasm of Purkinje neurons were reduced in 24-month in comparison with 11-month rats. Moreover, an increased accumulation of lipofuscin was noticeable in the cytoplasm of Purkinje neurons of old rats as well as an increase in MAO-B activity in the molecular layer of the cerebellar cortex. The two doses of L-deprenyl increased the density of both Purkinje and granule neuron profiles and the intensity of Nissl's staining in the cytoplasm of Purkinje neurons and reduced lipofuscin deposition within Purkinje neurons. The lower dose of L-deprenyl caused only a slight decrease in MAO-B activity, whereas the 5-mg/kg/day dose remarkably reduced it. These results suggest that long-term treatment with L-deprenyl counters the expression of some age-related microanatomical changes in the rat cerebellar cortex. The possible independence of the effects of the compound on age-related microanatomical changes of the cerebellar cortex and on MAO-B inhibitory activity is discussed.
用L-司来吉兰治疗可增加大鼠的平均寿命和最大寿命,并逆转与衰老相关的记忆和学习缺陷。由于关于L-司来吉兰给药对衰老脑微观解剖结构影响的信息稀少,我们研究了长期用L-司来吉兰治疗对老年大鼠小脑皮质结构的影响。之所以选用小脑皮质,是因为它是评估神经系统解剖结构和功能中与年龄相关变化的有用模型。雄性Sprague-Dawley大鼠在19至24月龄时,每日口服1.25mg/kg或5mg/kg的L-司来吉兰。年龄匹配的大鼠不接受治疗,用作对照组。11月龄未治疗的大鼠用作成年参照组。与11月龄大鼠相比,24月龄大鼠浦肯野神经元和颗粒神经元轮廓密度以及浦肯野神经元胞质内尼氏染色强度降低。此外,老年大鼠浦肯野神经元胞质中脂褐素积累增加,小脑皮质分子层中MAO-B活性也增加。两种剂量的L-司来吉兰均增加了浦肯野神经元和颗粒神经元轮廓密度以及浦肯野神经元胞质内尼氏染色强度,并减少了浦肯野神经元内脂褐素沉积。较低剂量的L-司来吉兰仅使MAO-B活性略有降低,而5mg/kg/天的剂量则使其显著降低。这些结果表明,长期用L-司来吉兰治疗可对抗大鼠小脑皮质中一些与年龄相关的微观解剖学变化的表达。本文还讨论了该化合物对小脑皮质与年龄相关微观解剖学变化的影响以及对MAO-B抑制活性的影响可能具有的独立性。